187 related articles for article (PubMed ID: 34046627)
1. Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases.
Cheng J; Feng X; Li Z; Zhou F; Yang JM; Zhao Y
RSC Med Chem; 2021 Apr; 12(4):552-565. PubMed ID: 34046627
[TBL] [Abstract][Full Text] [Related]
2. The Therapeutic Potential of Targeting NIK in B Cell Malignancies.
Haselager MV; Eldering E
Front Immunol; 2022; 13():930986. PubMed ID: 35911754
[TBL] [Abstract][Full Text] [Related]
3. NIK-IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation.
Kucharzewska P; Maracle CX; Jeucken KCM; van Hamburg JP; Israelsson E; Furber M; Tas SW; Olsson HK
J Cell Sci; 2019 Apr; 132(7):. PubMed ID: 30837284
[TBL] [Abstract][Full Text] [Related]
4. Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug design.
Crawford JJ; Feng J; Brightbill HD; Johnson AR; Wright M; Kolesnikov A; Lee W; Castanedo GM; Do S; Blaquiere N; Staben ST; Chiang PC; Fan PW; Baumgardner M; Wong S; Godemann R; Grabbe A; Wiegel C; Sujatha-Bhaskar S; Hymowitz SG; Liau N; Hsu PL; McEwan PA; Ismaili MHA; Landry ML
Bioorg Med Chem Lett; 2023 Jun; 89():129277. PubMed ID: 37105490
[TBL] [Abstract][Full Text] [Related]
5. TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation.
Hu WH; Mo XM; Walters WM; Brambilla R; Bethea JR
J Biol Chem; 2004 Aug; 279(34):35975-83. PubMed ID: 15208311
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule inhibitor of NF-κB-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury.
Ren X; Li X; Jia L; Chen D; Hou H; Rui L; Zhao Y; Chen Z
FASEB J; 2017 Feb; 31(2):711-718. PubMed ID: 27871061
[TBL] [Abstract][Full Text] [Related]
7. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of NF-kappaB-inducing kinase action.
Lin X; Mu Y; Cunningham ET; Marcu KB; Geleziunas R; Greene WC
Mol Cell Biol; 1998 Oct; 18(10):5899-907. PubMed ID: 9742107
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma inhibits hepatitis B virus-induced NF-kappaB activation through nuclear localization of NF-kappaB-inducing kinase.
Park SG; Ryu HM; Lim SO; Kim YI; Hwang SB; Jung G
Gastroenterology; 2005 Jun; 128(7):2042-53. PubMed ID: 15940636
[TBL] [Abstract][Full Text] [Related]
10. Involvement of a novel Rac/RhoA guanosine triphosphatase-nuclear factor-kappaB inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation.
Choudhary S; Lu M; Cui R; Brasier AR
Mol Endocrinol; 2007 Sep; 21(9):2203-17. PubMed ID: 17595324
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB inducing kinase (NIK) inhibitors: identification of new scaffolds using virtual screening.
Mortier J; Masereel B; Remouchamps C; Ganeff C; Piette J; Frederick R
Bioorg Med Chem Lett; 2010 Aug; 20(15):4515-20. PubMed ID: 20580552
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor κB-inducing kinase activation as a mechanism of pancreatic β cell failure in obesity.
Malle EK; Zammit NW; Walters SN; Koay YC; Wu J; Tan BM; Villanueva JE; Brink R; Loudovaris T; Cantley J; McAlpine SR; Hesselson D; Grey ST
J Exp Med; 2015 Jul; 212(8):1239-54. PubMed ID: 26122662
[TBL] [Abstract][Full Text] [Related]
13. NIK is a component of the EGF/heregulin receptor signaling complexes.
Chen D; Xu LG; Chen L; Li L; Zhai Z; Shu HB
Oncogene; 2003 Jul; 22(28):4348-55. PubMed ID: 12853971
[TBL] [Abstract][Full Text] [Related]
14. Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis.
Gray CM; McCorkell KA; Chunduru SK; McKinlay MA; May MJ
Biochem Biophys Res Commun; 2014 Jul; 450(1):341-6. PubMed ID: 24942881
[TBL] [Abstract][Full Text] [Related]
15. NIK inhibitor impairs chronic periodontitis via suppressing non-canonical NF-κB and osteoclastogenesis.
Wang J; Wang B; Lv X; Wang L
Pathog Dis; 2020 Oct; 78(7):. PubMed ID: 32860691
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo.
Li Z; Li X; Su MB; Gao LX; Zhou YB; Yuan B; Lyu X; Yan Z; Hu C; Zhang H; Luo C; Chen Z; Li J; Zhao Y
J Med Chem; 2020 Apr; 63(8):4388-4407. PubMed ID: 32216342
[TBL] [Abstract][Full Text] [Related]
17. A Kinase Assay for Measuring the Activity of the NIK-IKK1 Complex Induced via the Noncanonical NF-κB Pathway.
Mukherjee T; Ratra Y; Banoth B; Deka A; Polley S; Basak S
Methods Mol Biol; 2021; 2366():165-181. PubMed ID: 34236638
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.
Choudhary S; Boldogh S; Garofalo R; Jamaluddin M; Brasier AR
J Virol; 2005 Jul; 79(14):8948-59. PubMed ID: 15994789
[TBL] [Abstract][Full Text] [Related]
19. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.
Al-Sadi R; Guo S; Ye D; Rawat M; Ma TY
Am J Pathol; 2016 May; 186(5):1151-65. PubMed ID: 26948423
[TBL] [Abstract][Full Text] [Related]
20. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase.
Ramakrishnan P; Wang W; Wallach D
Immunity; 2004 Oct; 21(4):477-89. PubMed ID: 15485626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
